Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Raskob, Gary

One or more keywords matched the following items that are connected to Raskob, Gary

Item Type	Name
Concept	Enoxaparin
Academic Article	Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
Academic Article	A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.
Academic Article	Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
Academic Article	Oral rivaroxaban for symptomatic venous thromboembolism.
Academic Article	Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
Academic Article	Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin. Results from the AMPLIFY trial.
Academic Article	Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials.
Academic Article	Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
Academic Article	Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
Academic Article	Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.
Academic Article	Factor XI antisense oligonucleotide for prevention of venous thrombosis.
Academic Article	Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
Academic Article	Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
Academic Article	Apixaban or enoxaparin for thromboprophylaxis after knee replacement.
Academic Article	Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
Academic Article	Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
Academic Article	Oral apixaban for the treatment of acute venous thromboembolism.
Academic Article	Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
Academic Article	A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
Academic Article	Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Academic Article	Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial.
Academic Article	Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.
Academic Article	Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
Academic Article	Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER.
Academic Article	Milvexian for the Prevention of Venous Thromboembolism.
Academic Article	Abelacimab for Prevention of Venous Thromboembolism.
Academic Article	Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.

Search Criteria

Enoxaparin